Literature DB >> 24452763

Effects of unilateral phrenic nerve stimulation on tidal volume. First case report of a patient responding to remede® treatment for nocturnal Cheyne-Stokes respiration.

O Oldenburg1, T Bitter, H Fox, D Horstkotte, K-J Gutleben.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 24452763     DOI: 10.1007/s00059-013-4043-4

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


× No keyword cloud information.
  17 in total

Review 1.  Adaptive servoventilation for treatment of sleep-disordered breathing in heart failure: a systematic review and meta-analysis.

Authors:  Bhavneesh K Sharma; Jessie P Bakker; David G McSharry; Akshay S Desai; Shahrokh Javaheri; Atul Malhotra
Journal:  Chest       Date:  2012-11       Impact factor: 9.410

2.  Compliance with and effectiveness of adaptive servoventilation versus continuous positive airway pressure in the treatment of Cheyne-Stokes respiration in heart failure over a six month period.

Authors:  C Philippe; M Stoïca-Herman; X Drouot; B Raffestin; P Escourrou; L Hittinger; P-L Michel; S Rouault; M-P d'Ortho
Journal:  Heart       Date:  2005-06-17       Impact factor: 5.994

3.  Adaptive pressure support servo-ventilation: a novel treatment for Cheyne-Stokes respiration in heart failure.

Authors:  H Teschler; J Döhring; Y M Wang; M Berthon-Jones
Journal:  Am J Respir Crit Care Med       Date:  2001-08-15       Impact factor: 21.405

4.  Influence of obstructive sleep apnea on mortality in patients with heart failure.

Authors:  Hanqiao Wang; John D Parker; Gary E Newton; John S Floras; Susanna Mak; Kuo-Liang Chiu; Pimon Ruttanaumpawan; George Tomlinson; T Douglas Bradley
Journal:  J Am Coll Cardiol       Date:  2007-04-02       Impact factor: 24.094

5.  Trilevel adaptive servoventilation for the treatment of central and mixed sleep apnea in chronic heart failure patients.

Authors:  Olaf Oldenburg; Thomas Bitter; Birgit Wellmann; Thomas Fischbach; Christina Efken; Anke Schmidt; Dieter Horstkotte
Journal:  Sleep Med       Date:  2013-03-01       Impact factor: 3.492

6.  Pulmonary capillary wedge pressure and pulmonary arterial pressure in heart failure patients with sleep-disordered breathing.

Authors:  Olaf Oldenburg; Thomas Bitter; Marcus Wiemer; Christoph Langer; Dieter Horstkotte; Cornelia Piper
Journal:  Sleep Med       Date:  2009-01-08       Impact factor: 3.492

7.  A randomized controlled trial of adaptive ventilation for Cheyne-Stokes breathing in heart failure.

Authors:  Justin C T Pepperell; Nick A Maskell; David R Jones; Beverley A Langford-Wiley; Nicky Crosthwaite; John R Stradling; Robert J O Davies
Journal:  Am J Respir Crit Care Med       Date:  2003-08-19       Impact factor: 21.405

8.  Central sleep apnea, right ventricular dysfunction, and low diastolic blood pressure are predictors of mortality in systolic heart failure.

Authors:  Shahrokh Javaheri; Rakesh Shukla; Haoyue Zeigler; Laura Wexler
Journal:  J Am Coll Cardiol       Date:  2007-05-04       Impact factor: 24.094

9.  Sleep-disordered breathing in heart failure with normal left ventricular ejection fraction.

Authors:  Thomas Bitter; Lothar Faber; Detlef Hering; Christoph Langer; Dieter Horstkotte; Olaf Oldenburg
Journal:  Eur J Heart Fail       Date:  2009-06       Impact factor: 15.534

10.  Adaptive servoventilation improves cardiac function and respiratory stability.

Authors:  Olaf Oldenburg; Thomas Bitter; Roman Lehmann; Stefan Korte; Zisis Dimitriadis; Lothar Faber; Anke Schmidt; Nina Westerheide; Dieter Horstkotte
Journal:  Clin Res Cardiol       Date:  2010-09-12       Impact factor: 5.460

View more
  2 in total

Review 1.  Transvenous phrenic nerve stimulation, a novel therapeutic approach for central sleep apnea.

Authors:  Ning Ding; Xilong Zhang
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

Review 2.  The importance of sleep-disordered breathing in cardiovascular disease.

Authors:  Dominik Linz; Holger Woehrle; Thomas Bitter; Henrik Fox; Martin R Cowie; Michael Böhm; Olaf Oldenburg
Journal:  Clin Res Cardiol       Date:  2015-04-23       Impact factor: 5.460

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.